Date post: | 08-Jul-2015 |
Category: |
Business |
Upload: | daniel-schwartz |
View: | 124 times |
Download: | 0 times |
Insights into the Supply Planning
Process
Courtney Clark, Jan Szydlowski, Sergio Rivera
Claudia De Bourg, Daniel Schwartz, Rex Agbajor
Supply & Demand
Group #2
The MPS at
GlaxoSmithKli
ne
Agenda
Company Overview
Operations
Supply Planning Process
Master Production Schedule (MPS)
Q&A
2
Company Overview
GSK Focus
Pharmaceuticals
Vaccines
Consumer Healthcare
(GSK Canada, 2014)
3
Company Overview
GSK Targets
Respiratory Illnesses
Diabetes
Viral Control
Infections
Central Nervous System Disorders
Scale of GSK
99 000+ employed
Operating in 115 countries
CAD $47 billion annual revenue in 2013
4
Operations
GSK Mississauga Facility
Sells exclusively to internal GSK customers
Produces liquids, tablets and ointments
Components of Finished Goods
Active Pharmaceutical Ingredients (API) -
substances that are responsible for the beneficial
health effects
Excipients – preservatives / stability materials
Primary and Secondary Components - packaging
5
Supply Planning Process -
Demand
Forecasts for:
USA (Mainly)
Latin America
Parts of Asia
(I.e. Japan)
Parts of
Europe
Canada
(<10%)
Family Level
(J. Shang et al. 2008)
6
Supply Planning Process –
S&OP
Vital
component of
the process
Integrates all
departments
Shapes
demand inputs
for MPS
7
(J. Shang et al. 2008)
Supply Planning Process –
Inventory Raw Materials
Highly perishable
Expensive
Major Risk
Finished Good
Not inventoried
Longer shelf life
Distributor carries risk
Must be monitored very closely through ERP
8
(J. Shang et al. 2008)
Supply Planning Process
(J. Shang et al. 2008)
*Continu
ous Loop
9
Key Role “Functional Areas”
Safety Stock
10
Master Production Schedule
INPUTS
SAP
OUTPUTS
11
Master Production Schedule
(J. Shang et al. 2008)
RUNNING
RATES
DEMAND
PLANNER
-FC ERRORS
-OUTLIERS
-
CONSTRAINT
S
MPS
12
Master Production Schedule
13
Thank YouQ&A